Crossroads between innate and adaptive immunity /
Saved in:
Meeting name: | Crossroads Between Innate and Adaptive Immunity Conference (1st : 2005 : Rhodes, Greece) |
---|---|
Imprint: | New York : Springer, c2007. |
Description: | xx, 232 p., [1] leaf of plates : ill. (some col.) ; 25 cm. |
Language: | English |
Series: | Advances in experimental medicine and biology, 0065-2598 ; v. 590 |
Subject: | |
Format: | E-Resource Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/6243856 |
Table of Contents:
- List of Contributors
- 1. Signal Transduction in DC Differentiation: Winged Messengers and Achilles' Heel
- 1. Introduction
- 2. Dendritic Cell Functional Diversity
- 3. DC Progenitors
- 4. Winged Messengers - Signaling Pathways that Drive DC Differentiation
- 4.1. Extracellular Stimuli
- 4.2. Intracellular Signal Transduction
- 5. Achilles' Heel - Subversion of DC Differentiation by Pathogen-Mediated Disruption of Signal Transduction Pathways
- 5.1. Yersinia and the Disruption of Intracellular Signaling Pathways
- 5.2. Yersinia and DC Differentiation
- 6. Concluding Remarks
- 7. References
- 2. Shaping Naive and Memory CD8+T Cell Responses in Pathogen Infections through Antigen Presentation
- 1. Introduction
- 2. Dendritic Cells of Spleen and Lymph Nodes
- 3. Role of Dendritic Cells in Pathogen Responses
- 3.1. Priming Naive T Cells
- 3.2. Identifying the Main Movers and Shakers in Infection
- 3.3. Dendritic Cell Subsets in Pathogen Infections
- 3.4. Amplification of Memory CD8+T Cells in Secondary Infections
- 4. Conclusions
- 5. Acknowledgments
- 6. References
- 3. Understanding the Role of Innate Immunity in the Mechanism of Action of the Live Attenuated Yellow Fever Vaccine 17D
- 1. Introduction: A Historical Perspective
- 2. Understanding the Innate Immune Mechanism of Action of YF-17D
- 3. Concluding Remarks
- 4. Acknowledgments
- 5. References
- 4. The Function of Local Lymphoid Tissues in Pulmonary Immune Responses
- 1. Lymph Node Structure and Development
- 2. Role of Local Lymphoid Organs in Pulmonary Immunity
- 2.1. Structure and Function of Nasal-Associated Lymphoid Tissue (NALT)
- 2.2. Pulmonary Immune Responses in the Absence of Secondary Lymphoid Organs
- 2.3. Structure and Function of Bronchus-Associated Lymphoid Tissue (BALT)
- 2.4. Does iBALT Confer Antiinflammatory Properties on Local Immune Responses?
- 3. Conclusions and Future Directions
- 4. Acknowledgments
- 5. References
- 5. The Yin and Yang of Adaptive Immunity in Allogeneic Hematopoietic Cell Transplantation: Donor Antigen-Presenting Cells Can Either Augment or Inhibit Donor T Cell Alloreactivity
- 1. Introduction
- 2. Materials and Methods
- 2.1. Mice
- 2.2. LBRM Tumor Cell Line
- 2.3. Donor Cell Preparations
- 2.4. BM CD11b Depletion and Splenic T Cell Purification
- 2.5. Recipient Mice Conditioning
- 2.6. BMT and Leukemia Challenge
- 2.7. Analyses of DC Subsets and DC Precursors in BM and Spleen Grafts
- 2.8. Analyses of Hematopoietic Engraftment of Transplant Recipients
- 2.9. Serum Gamma Interferon (IFN-[gamma]) and Tumor Necrosis Factor-Alpha (TNF-[alpha]) Enzyme-Linked Immunosorbent Assay (ELISA)
- 2.10. Assessments of Survival and GvHD in Transplant Recipients
- 2.11. Statistical Analyses
- 3. Results
- 3.1. MACs Depletion of CD11b[superscript +] Cells in the BM Graft Does not Affect Stem Cell Content
- 3.2. Transplanting Manipulated BM Grafts in the Absence of Added Splenocytes Did not Lead to Graft Rejection or GvHD
- 3.3. CD11b-Depleted BM Grafts Combined with Low-Dose Splenocytes or Splenic T Cells Led to Slight Enhancement of Non-Lethal GvHD in Recipients of Allogeneic BMT
- 3.4. CD11b[superscript +] Cell-Enriched BM Grafts Combined with Low-Dose Splenocytes or Splenic T Cells Inhibited GvHD in Recipients of Allogeneic BMT
- 3.5. No Combinations of Unmanipulated BM and Splenocytes Produced a GvL Effect without also Causing Lethal GvHD
- 3.6. The Combination of CD11b-Depleted BM and Low-Dose Donor Splenocytes Led to a Durable GvL Effect without GvHD
- 3.7. Recipients of CD11b-Depleted BM Grafts Had Increased Numbers of Donor Spleen-Derived Memory T Cells in the Blood Post-Transplant
- 3.8. Recipients of CD11b-Depleted Allogeneic BMT Had Increased Levels of Serum IFN-[gamma] at Day +30 Post-BMT
- 4. Discussion
- 5. Acknowledgments
- 6. References
- 6. It's Only Innate Immunity But I Like It
- 1. Introduction
- 2. The Immunoregulatory Role of NK Cells: Crosstalk between NK, MDDC, and PDC
- 3. Crosstalk between Innate and Adaptive Immune Responses
- 4. Involvement of Neutrophils in the Regulation of Adaptive Immune Responses through Interactions with Other Innate Effector Cells
- 5. Other Innate Cells Such as Mast Cells or Eosinophils Are Important in the Early Phases of Innate Immune Responses
- 6. Concluding Remarks
- 7. Ackowledgments
- 8. References
- 7. Innate Tumor Immune Surveillance
- 1. Introduction
- 2. Type I Interferon
- 3. NKG2D
- 4. Cytokines that Act via NKG2D
- 5. Acknowledgments
- 6. References
- 8. Regulation of Adaptive Immunity by Cells of the Innate Immune System: Bone Marrow Natural Killer Cells Inhibit T Cell Proliferation
- 1. Introduction
- 2. Regulatory Function of NK Cells
- 3. NK Cells Inhibit by a Non-Cytotoxic Mechanism
- 4. NK Cells Inhibit Cell Cycle Progression
- 5. Bone Marrow-Derived NK Cells Have Unique Function
- 6. Role of NK Cells in Immune Homeostasis
- 7. Acknowledgments
- 8. References
- 9. Induction and Maintenance of CD8+T Cells Specific for Persistent Viruses
- 1. Persistent Viruses Are Prevalent in Human and Mice
- 2. General Effects of Persistent Viruses on the Host Immune System
- 3. Generation of CD8+ Memory T Cells
- 4. Function of Memory CD8+ T Cells Specific for Persistent Viruses
- 5. Phenotype of Memory CD8+ T Cells Specific for Persistent Viruses
- 6. Maintenance of Memory CD8+ T Cells Specific for Persistent Viruses
- 7. Regulation of IL-7R[alpha] Expression by the Presence of Antigen
- 8. Concluding Remarks
- 9. References
- 10. Germinal Center-Derived B Cell Memory
- 1. Introduction
- 2. Materials and Methods
- 2.1. Mice and Immunizations
- 2.2. [Beta]-Galactosidase Detection, Antibodies, and Flow Cytometry
- 2.3. ELISPOT Assay
- 2.4. Cell Sorting and Adoptive Transfers
- 2.5. PCR and DNA Sequencing
- 2.6. Statistics
- 3. Results
- 3.1. Generation of Germinal Center-Cre Transgenic Mice
- 3.2. Splenic [Beta]-gal Expression Is Induced upon Immunization
- 3.3. [Beta]-Galactosidase Expression Does not Mark All GC B Cells
- 3.4. [Beta]-gal[superscript +] GC B Cells Contain Mutated [lambda][subscript 1] V Regions
- 3.5. Hypermutated [Beta]-gal[superscript +] Memory B Cells Transfer Ag Recall Responses
- 4. Conclusion
- 5. References
- 11. CD28 and CD27 Costimulation of CD8+ T Cells: A Story of Survival
- 1. Introduction
- 2. Classical and Alternative Costimulation
- 3. T Cell Development
- 4. Antigen-Specific T Cell Responses
- 5. Memory, Antigenic Rechallenge, and Secondary Responses
- 6. Summary and Conclusions
- 7. References
- 12. CD38: An Ecto-Enzyme at the Crossroads of Innate and Adaptive Immune Responses
- 1. Introduction
- 2. CD38 Regulates Innate and Adaptive Immune Responses
- 2.1. CD38 Regulates Neutrophil Migration and Lung Inflammatory Responses
- 2.2. CD38 Regulates Dendritic Cell Trafficking in Vitro and in Vivo
- 2.3. CD38 Regulates T Cell-Dependent Immune Responses
- 3. CD38 Modulates Chemokine Receptor Signaling by Producing Calcium Mobilizing Metabolites
- 4. Conclusions and Future Directions
- 4.1. Unresolved Questions
- 4.2. Model
- 5. Acknowledgments
- 6. References
- 13. Vascular Leukocytes: A Population with Angiogenic and Immunossuppressive Properties Highly Represented in Ovarian Cancer
- 1. Physiological Angiogenesis vs. Pathological Angiogenesis
- 2. Endothelial Progenitors and Neoangiogenesis
- 3. Hematopoietic Cells Participate in Neoangiogenesis
- 4. Antigen-Presenting Cells as Endothelial Cells
- 5. Tumor Angiogenesis
- 6. Vascular Leukocytes
- 7. Vascular Leukocytes and Antitumor Immune Response
- 8. Final Remarks
- 9. Acknowledments
- 10. References
- 14. CD4+ T Cells Cooperate with Macrophages for Specific Elimination of MHC Class II-Negative Cancer Cells
- 1. Introduction
- 2. CD4+ T Cells Help CD8+ T Cells to Kill Tumor Cells
- 3. CD4+ T Cells Can Reject Tumors in the Absence of CD8+ T Cells
- 4. Cancer Immunotherapy by Adoptive Transfer of Tumor-Specific CD4+ T Cells
- 5. CD4+ T Cells in Cancer Immunosurveillance
- 5.1. Injection of Tumor Cells in Matrigel
- 5.2. Naive Tumor-Specific CD4+ T Cells Become Activated in Draining Lymph Nodes (LN), Migrate to the Incipient Tumor Site and Secrete Cytokines
- 5.3. Massive Recruitment of Host Macrophages toward the Injected Myeloma Cells
- 5.4. Tumor-Specific CD4+ T Cells Activate Matrigel-Infiltrating Macrophages
- 5.5. IFN[gamma] Is Critical for T Cell-Mediated Macrophage Activation and Tumor Rejection
- 5.6. T Cell-Activated Macrophages Suppress Tumor Cell Growth
- 6. Conclusions
- 7. Acknowledgments
- 8. References
- 15. Receptors and Pathways in Innate Antifungal Immunity: The Implication for Tolerance and Immunity to Fungi
- 1. Introduction
- 2. What and Which Are Opportunistic Fungal Pathogens?
- 3. The Immune Response to Fungi: From Microbe Sensing to Host Defencing
- 4. Sensing Fungi
- 5. Tuning the Adaptive Immune Responses: the Instructive Role of DCs
- 6. DCs as Tolerance Mediators via Tryptophan Catabolism
- 7. Dampening Inflammation and Allergy to Fungi through Treg
- 8. Looking Forward
- 9. Acknowledgments
- 10. References
- Author Index
- Subject Index